{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:48:32Z","timestamp":1791823712536,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"DOI":"10.1186\/s12978-026-02409-7","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:43:31Z","timestamp":1784159011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of prescription medications potentially harmful during pregnancy among women of reproductive age by pregnancy status and contraceptive use in the United States, 2009\u20132020"],"prefix":"10.1186","volume":"23","author":[{"given":"Dima M.","family":"Qato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Ozenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"2409_CR1","doi-asserted-by":"publisher","unstructured":"Haas DMMD, Marsh MS, Dang DJMS, Parker DTMD, Wing CBDPH, MD DA, Simhan MBA, Hyagriv NMD, Grobman WA, MD MBA, Mercer BMMD, Silver RMMD, Hoffman MKMD, Parry SMD, Iams JDMD, Caritis SNMD, Wapner RJMD, Esplin M, Sean MD, Elovitz MAMD, Peaceman AMMD, Chung JMD, Saade GRMD, Reddy UM. MD, MPH; for the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be (nuMoM2b) Study. Prescription and Other Medication Use in Pregnancy. Obstetrics & Gynecology 131(5):p 789\u2013798, May 2018. | https:\/\/doi.org\/10.1097\/AOG.0000000000002579.","DOI":"10.1097\/AOG.0000000000002579"},{"key":"2409_CR2","doi-asserted-by":"publisher","unstructured":"Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hern\u00e1ndez-D\u00edaz S, National Birth Defects Prevention Study. Medication use during pregnancy, with particular focus on prescription drugs: 1976\u20132008. Am J Obstet Gynecol. 2011;205(1):51.e1-8. https:\/\/doi.org\/10.1016\/j.ajog.2011.02.029. Epub 2011 Apr 22. PMID: 21514558; PMCID: PMC3793635.","DOI":"10.1016\/j.ajog.2011.02.029"},{"key":"2409_CR3","doi-asserted-by":"publisher","unstructured":"Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191(2):398\u2013407. https:\/\/doi.org\/10.1016\/j.ajog.2004.04.025. PMID: 15343213.","DOI":"10.1016\/j.ajog.2004.04.025"},{"issue":"5","key":"2409_CR4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s10995-014-1611-z","volume":"19","author":"SC Tinker","year":"2015","unstructured":"Tinker SC, Broussard CS, Frey MT, Gilboa SM. Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999\u20132006. Matern Child Health J. 2015;19(5):1097\u2013106. https:\/\/doi.org\/10.1007\/s10995-014-1611-z . PMID: 25287251; PMCID: PMC4515960.","journal-title":"Matern Child Health J"},{"key":"2409_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.12.020","author":"O Mansour","year":"2024","unstructured":"Mansour O, Russo RG, Straub L, et al. Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence. Am J Obstet Gynecol Published online. 2024. https:\/\/doi.org\/10.1016\/j.ajog.2023.12.020.","journal-title":"Am J Obstet Gynecol Published online"},{"issue":"22","key":"2409_CR6","doi-asserted-by":"publisher","first-page":"e33828","DOI":"10.1097\/MD.0000000000033828","volume":"102","author":"YC Chang","year":"2023","unstructured":"Chang YC, Huang HY, Shen TH, Wu CH. Prevalence, trends, and characteristics of polypharmacy among US pregnant women aged 15 to 44 years: NHANES 1999 to 2016. Med (Baltim). 2023;102(22):e33828. : 10.1097\/MD.0000000000033828. PMID: 37266635; PMCID: PMC10238014.10.1097\/MD.0000000000033828. PMID: 37266635; PMCID: PMC10238014.","journal-title":"Med (Baltim)"},{"key":"2409_CR7","unstructured":"Centers for Disease Control and Prevention (CDC). Unintended pregnancy. CDC. May 15, 2024. Available from: https:\/\/www.cdc.gov\/reproductive-health\/hcp\/unintended-pregnancy\/index.html. Cited 01 Jul 2026."},{"key":"2409_CR8","doi-asserted-by":"publisher","unstructured":"Rossen LM, Hamilton BE, Abma JC, Gregory ECW, Beresovsky V, Resendez AV, et al. Updated methodology to estimate overall and unintended pregnancy rates in the United States. National Center for Health Statistics. Vital Health Stat. 2023;2(201). https:\/\/doi.org\/10.15620\/cdc:124395.","DOI":"10.15620\/cdc:124395"},{"key":"2409_CR9","unstructured":"Food US, Administration D. Pregnancy and lactation labeling resources. Silver Spring (MD): FDA; 2014 Dec 3. Updated 2025. Available from: https:\/\/www.fda.gov\/drugs\/labeling-information-drug-products\/pregnancy-and-lactation-labeling-resources. Cited 11 Jun 2025."},{"issue":"6","key":"2409_CR10","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.jaip.2020.01.056","volume":"8","author":"J Namazy","year":"2020","unstructured":"Namazy J, Chambers C, Sahin L, Johnson T, Dinatale M, Lappin B, Schatz M. Clinicians\u2019 perspective of the new Pregnancy and Lactation Labeling Rule (PLLR): Results from an AAAAI\/FDA survey. J Allergy Clin Immunol Pract. 2020;8(6):1947\u201352. https:\/\/doi.org\/10.1016\/j.jaip.2020.01.056.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"2409_CR11","first-page":"713","volume":"41","author":"S Pernia","year":"2016","unstructured":"Pernia S, DeMaagd G. The New Pregnancy and Lactation Labeling Rule. P T. 2016;41(11):713\u20135. PMID: 27904304; PMCID: PMC5083079.","journal-title":"P T"},{"key":"2409_CR12","doi-asserted-by":"publisher","unstructured":"Dude C, Jamieson DJ. Assessment of the Safety of Common Medications Used During Pregnancy. JAMA. 2021;326(23):2421\u20132422. https:\/\/doi.org\/10.1001\/jama.2021.20191. PMID: 34932091.","DOI":"10.1001\/jama.2021.20191"},{"issue":"8","key":"2409_CR13","doi-asserted-by":"publisher","first-page":"e2015094","DOI":"10.1001\/jamanetworkopen.2020.15094","volume":"3","author":"JJ Byrne","year":"2020","unstructured":"Byrne JJ, Saucedo AM, Spong CY. Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule. JAMA Netw Open. 2020;3(8):e2015094. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.15094 . PMID: 32865574; PMCID: PMC7489861.","journal-title":"JAMA Netw Open"},{"key":"2409_CR14","unstructured":"Roca C. An evolution of labeling information for pregnant women: PLLR history and background. Silver Spring (MD): U.S. Food and Drug Administration, CDER; 2018 Mar 5. . Cited 11 Jun 2025."},{"key":"2409_CR15","doi-asserted-by":"publisher","unstructured":"Sarayani A, Albogami Y, Thai TN, Smolinski NE, Patel P, Wang Y, Nduaguba S, Rasmussen SA, Winterstein AG. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies. Am J Obstet Gynecol. 2022;227(2):263.e1-263.e38. https:\/\/doi.org\/10.1016\/j.ajog.2022.01.004. Epub 2022 Jan 12. PMID: 35032444.","DOI":"10.1016\/j.ajog.2022.01.004"},{"issue":"2","key":"2409_CR16","doi-asserted-by":"publisher","first-page":"e2354298","DOI":"10.1001\/jamanetworkopen.2023.54298","volume":"7","author":"AG Winterstein","year":"2024","unstructured":"Winterstein AG, Wang Y, Smolinski NE, Thai TN, Ewig C, Rasmussen SA. Prenatal Care Initiation and Exposure to Teratogenic Medications. JAMA Netw Open. 2024;7(2):e2354298. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.54298 . PMID: 38300617; PMCID: PMC10835507.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2409_CR17","doi-asserted-by":"publisher","first-page":"e3141","DOI":"10.1016\/j.ajog.2010.12.039","volume":"204","author":"CS Broussard","year":"2011","unstructured":"Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, Honein MA, National Birth Defects Prevention Study. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204(4):e3141\u201311. Epub 2011 Feb 23. PMID: 21345403.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"2409_CR18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjc.6690469","volume":"80","author":"E Hemminki","year":"1999","unstructured":"Hemminki E, Gissler M, Toukomaa H. Exposure to female hormone drugs during pregnancy: effect on malformations and cancer. Br J Cancer. 1999;80(7):1092\u20137. https:\/\/doi.org\/10.1038\/sj.bjc.6690469 . PMID: 10362122; PMCID: PMC2363045.","journal-title":"Br J Cancer"},{"key":"2409_CR19","doi-asserted-by":"publisher","unstructured":"Ornoy A, Koren G. Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure? Birth Defects Res. 2017;109(12):898\u2013908. https:\/\/doi.org\/10.1002\/bdr2.1078. PMID: 28714608.","DOI":"10.1002\/bdr2.1078"},{"key":"2409_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.reprotox.2019.05.066","volume":"87","author":"EA Verberne","year":"2019","unstructured":"Verberne EA, de Haan E, van Tintelen JP, Lindhout D, van Haelst MM. Fetal methotrexate syndrome: A systematic review of case reports. Reprod Toxicol. 2019;87:138\u201346. https:\/\/doi.org\/10.1016\/j.reprotox.2019.05.066.","journal-title":"Reprod Toxicol"},{"key":"2409_CR21","unstructured":"Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey (NHANES). Hyattsville (MD): National Center for Health Statistics. Available from: https:\/\/www.cdc.gov\/nchs\/nhanes\/index.html. Cited 11 Jun 2025."},{"key":"2409_CR22","unstructured":"Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey: Prescription Medications Data Documentation, Codebook, and Frequencies. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: https:\/\/wwwn.cdc.gov\/nchs\/nhanes."},{"key":"2409_CR23","unstructured":"Micromedex\u00ae (electronic version). Merative, Ann Arbor, Michigan, USA. Available at: https:\/\/www-micromedexsolutions-com.proxy.cc.uic.edu\/. Cited 11 Jun 2025."},{"key":"2409_CR24","unstructured":"IBM Micromedex. MICROMEDEX Healthcare Series. Greenwood Village (CO): IBM Corporation. Available from: https:\/\/www.micromedexsolutions.com\/infobutton\/librarian\/access\/PFActionId\/infobutton.ShowDrugsPopUp?itemId=373500&xrefId=thPregnancy&type=hidden&contentSetId=100. Cited 11 Jun 2025."},{"key":"2409_CR25","unstructured":"StataCorp S. Data analysis and statistical software. College Station (TX): StataCorp LLC. Available from: https:\/\/www.stata.com\/. Cited 11 Jun 2025."},{"key":"2409_CR26","unstructured":"List of Pregnancy Exposure Registries. - From the FDA Office of Women\u2019s Health. https:\/\/www.fda.gov\/consumers\/pregnancy-exposure-registries\/list-pregnancy-exposure-registries. Cited 24 Nov 2025."},{"key":"2409_CR27","unstructured":"MotherToBaby. https:\/\/mothertobaby.org\/affiliates\/mothertobaby-california\/. Cited 24 Nov 2025."},{"issue":"3","key":"2409_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/AOG.0000000000000982","volume":"126","author":"K Palmsten","year":"2015","unstructured":"Palmsten K, Hern\u00e1ndez-D\u00edaz S, Chambers CD, Mogun H, Lai S, Gilmer TP, Huybrechts KF. The Most Commonly Dispensed Prescription Medications Among Pregnant Women Enrolled in the U.S. Medicaid Program. Obstet Gynecol. 2015;126(3):465\u201373. PMID: 26244530; PMCID: PMC4651654.","journal-title":"Obstet Gynecol"},{"key":"2409_CR29","doi-asserted-by":"publisher","unstructured":"Cooper WO, Willy ME, Pont SJ, Ray WA. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol. 2007;196(6):544.e1-5. https:\/\/doi.org\/10.1016\/j.ajog.2007.01.033. PMID: 17547888.","DOI":"10.1016\/j.ajog.2007.01.033"},{"key":"2409_CR30","doi-asserted-by":"publisher","first-page":"204209862513837","DOI":"10.1177\/20420986251383765","volume":"16","author":"J Zheng","year":"2025","unstructured":"Zheng J, Zhang Z, Ma L, Su L. Real-world pharmacovigilance study on neonatal congenital anomalies associated with maternal drug exposure using the FDA Adverse Event Reporting System. Ther Adv Drug Saf. 2025;16:20420986251383765. https:\/\/doi.org\/10.1177\/20420986251383765.","journal-title":"Ther Adv Drug Saf"},{"key":"2409_CR31","doi-asserted-by":"publisher","unstructured":"Bernhardsen GP, Pesonen M, Keski-Nisula L, Nordeng H, Lehto SM. Trajectories of Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Perinatal Outcomes: A Longitudinal Register Study. BJOG. 2025 Aug 20. https:\/\/doi.org\/10.1111\/1471-0528.18337.","DOI":"10.1111\/1471-0528.18337"},{"issue":"2","key":"2409_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.mayocpiqo.2023.02.002","volume":"7","author":"JE Brumbaugh","year":"2023","unstructured":"Brumbaugh JE, Ball CT, Crook JE, Stoppel CJ, Carey WA, Bobo WV. Poor Neonatal Adaptation After Antidepressant Exposure During the Third Trimester in a Geographically Defined Cohort. Mayo Clin Proc Innov Qual Outcomes. 2023;7(2):127\u201339. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2023.02.002.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"8","key":"2409_CR33","doi-asserted-by":"publisher","first-page":"e2228588","DOI":"10.1001\/jamanetworkopen.2022.28588","volume":"5","author":"DB Esposito","year":"2022","unstructured":"Esposito DB, Huybrechts KF, Werler MM, Straub L, Hern\u00e1ndez-D\u00edaz S, Mogun H, Bateman BT. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns. JAMA Netw Open. 2022;5(8):e2228588. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.28588.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2409_CR34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/aogs.14363","volume":"101","author":"IK S\u00f8rbye","year":"2022","unstructured":"S\u00f8rbye IK, Haualand R, Wiull H, Letting AS, Langesaeter E, Estensen ME. Maternal beta-blocker dose and risk of small-for gestational-age in women with heart disease. Acta Obstet Gynecol Scand. 2022;101(7):794\u2013802. https:\/\/doi.org\/10.1111\/aogs.14363.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"2409_CR35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1365-2125.2007.02901.x","volume":"64","author":"F B\u00e1nhidy","year":"2007","unstructured":"B\u00e1nhidy F, Acs N, Puh\u00f3 E, Czeizel AE. Ergotamine treatment during pregnancy and a higher rate of low birthweight and preterm birth. Br J Clin Pharmacol. 2007;64(4):510\u20136. https:\/\/doi.org\/10.1111\/j.1365-2125.2007.02901.x . Epub 2007 May 15. PMID: 17506783; PMCID: PMC2048564.","journal-title":"Br J Clin Pharmacol"},{"key":"2409_CR36","doi-asserted-by":"publisher","unstructured":"Huybrechts KF, Bateman BT, Hern\u00e1ndez-D\u00edaz S. Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy. Pharmacoepidemiol Drug Saf. 2019;28(7):906\u201322. https:\/\/doi.org\/10.1002\/pds.4789 . Epub 2019 May 10. PMID: 31074570; PMCID: PMC6823105.","DOI":"10.1002\/pds.4789"},{"key":"2409_CR37","doi-asserted-by":"publisher","unstructured":"Sundermann AC, Hartmann KE, Jones SH, Torstenson ES, Velez Edwards DR. Validation of maternal recall of early pregnancy medication exposure using prospective diary data. Ann Epidemiol. 2017;27(2):135\u2013e1392. https:\/\/doi.org\/10.1016\/j.annepidem.2016.11.015. Epub 2016 Dec 9. PMID: 28012836; PMCID: PMC5685497.","DOI":"10.1016\/j.annepidem.2016.11.015"},{"key":"2409_CR38","doi-asserted-by":"publisher","unstructured":"Sundermann AC, Hartmann KE, Jones SH, Torstenson ES, Velez Edwards DR. Validation of maternal recall of early pregnancy medication exposure using prospective diary data. Ann Epidemiol. 2017;27(2):135\u2013e1392. https:\/\/doi.org\/10.1016\/j.annepidem.2016.11.015. Epub 2016 Dec 9. PMID: 28012836; PMCID: PMC5685497.","DOI":"10.1016\/j.annepidem.2016.11.015"},{"issue":"5","key":"2409_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamaneurol.2024.0258","volume":"81","author":"D Battino","year":"2024","unstructured":"Battino D, Tomson T, Bonizzoni E, Craig J, Perucca E, Sabers A, Thomas S, Alvestad S, Perucca P, Vajda F, EURAP Collaborators. Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy. JAMA Neurol. 2024;81(5):481\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2024.0258.","journal-title":"JAMA Neurol"},{"issue":"23","key":"2409_CR40","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","volume":"376","author":"E Patorno","year":"2017","unstructured":"Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, Cohen LS, Hernandez-Diaz S. Lithium Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med. 2017;376(23):2245\u201354. https:\/\/doi.org\/10.1056\/NEJMoa1612222.","journal-title":"N Engl J Med"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-026-02409-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-026-02409-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-026-02409-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:03:46Z","timestamp":1791821026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12978-026-02409-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2409"],"URL":"https:\/\/doi.org\/10.1186\/s12978-026-02409-7","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted using publicly available, de-identified data and was therefore exempt from institutional review board approval. Informed consent was obtained by the NHANES and all analyses were conducted in accordance with relevant guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"182"}}